Shopping Cart
Remove All
Your shopping cart is currently empty
MK-8353 (SCH900353) is a potent, selective, and orally available inhibitor of ERK1/2 with IC50 values of 23.0 nM and 8.8 nM, respectively.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $74 | In Stock | In Stock | |
| 5 mg | $158 | In Stock | In Stock | |
| 10 mg | $286 | In Stock | In Stock | |
| 25 mg | $652 | In Stock | In Stock | |
| 50 mg | $987 | - | In Stock | |
| 100 mg | $1,530 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $242 | In Stock | In Stock |
| Description | MK-8353 (SCH900353) is a potent, selective, and orally available inhibitor of ERK1/2 with IC50 values of 23.0 nM and 8.8 nM, respectively. |
| Targets&IC50 | ERK1:23 nM, ERK2:8.8 nM |
| In vitro | MK-8353 is a potent, selective, and orally available ERK1/2 inhibitor with IC50 values of 23.0 nM and 8.8 nM, respectively; it exhibits antitumor activity. |
| In vivo | MK-8353 causes at least 50% tumor growth inhibition or regression in 83% of the animal models bearing different tumor cells[1]. |
| Synonyms | SCH900353 |
| Molecular Weight | 691.84 |
| Formula | C37H41N9O3S |
| Cas No. | 1184173-73-6 |
| Smiles | CS[C@]1(CCN(CC(=O)N2CCC(=CC2)c2ccc(cc2)-c2ncn(C)n2)C1)C(=O)Nc1ccc2[nH]nc(-c3ccc(OC(C)C)nc3)c2c1 |
| Relative Density. | 1.36 g/cm3 (Predicted) |
| Color | Orange |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 125 mg/mL (180.68 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (5.78 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.